Cell line · CVCL_1100
Papers65
1 to 20 of 65
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Systematic Workflow Optimization for Ultra-sensitive Targeted Immunopeptidomics. | Mol Cell Proteomics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GATA3 Inhibits the Expression of Viral E6/E7 Genes, and Its Expression Is Compromised During HPV-Mediated Cervical Carcinogenesis. | J Med Virol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy. | Neoplasia | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Gene Expression Profiling and Prognostic Significance of Nuclear and Membrane Progesterone Receptors in Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Development of a novel multi-locus Flow-FISH based assay for detection of progressive cervical precancer lesions. | BMC Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy. | medRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Alkyltriphenylphosphonium Binding to Cardiolipin Triggers Oncosis in Cancer Cells. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Factors that determine cell fate in mitotically arrested cancer cells. | Front Cell Dev Biol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| MCPyV small T antigen enhances HPV16 oncogene expression, promotes Ca Ski cell proliferation, and reduces 5-fluorouracil-induced apoptosis in cervical cancer cells. | Infect Med (Beijing) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts. | Oncoimmunology | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Protein Biomarkers Enable Sensitive and Specific Cervical Intraepithelial Neoplasia (CIN) II/III+ Detection: One Step Closer to Universal Cervical Cancer Screening. | Cancers (Basel) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Hypoxic HPV-Positive Cancer Cells Are Particularly Sensitive to the Pro-Senescent Effects of B-MYB Repression Due to the Lack of Compensatory A-MYB Induction. | J Med Virol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in cervical cancer. | Cell Death Dis | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma. | Int J Mol Sci | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Targeting HSP70-E7 Interaction With SHetA2: A Novel Therapeutic Strategy for Cervical Cancer. | J Med Virol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies. | EBioMedicine | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of ADAM17 increases the cytotoxic effect of cisplatin in cervical spheroids and organoids. | Front Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines. | BMC Cancer | 2024 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1100/papers